TODAY'S MARKET INTELLIGENCE
IHE vs. XBI: Pharma Stability or Biotech Growth -- Which Healthcare ETF Is the Better Buy?
English summary
XBI has risen nearly 80% over the past year but has experienced a much larger maximum drawdown over five years; IHE offers steadier returns and a higher dividend yield. The article compares risk-return profiles without explicit advice.
The English text is machine translated and may require verification against the Chinese version.
Browse today's intelligence